Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Albany Molecular Res (AMRI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 932,662
  • Shares Outstanding, K 42,960
  • Annual Sales, $ 570,450 K
  • Annual Income, $ -70,170 K
  • 36-Month Beta 1.18
  • Price/Sales 1.63
  • Price/Cash Flow 10.84
  • Price/Book 3.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.59 +0.51%
on 06/21/17
21.78 -0.37%
on 07/05/17
+0.12 (+0.56%)
since 06/20/17
3-Month
15.30 +41.83%
on 05/05/17
22.17 -2.12%
on 06/05/17
+5.92 (+37.52%)
since 04/20/17
52-Week
13.01 +66.79%
on 03/23/17
22.17 -2.12%
on 06/05/17
+7.08 (+48.43%)
since 07/20/16

Most Recent Stories

More News
Uptrend Call Working As Albany Molecular Stock Rises 41.1% (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 3 months, Albany Molecular has returned 41.11% as of today's recent price of $21.71.

AMRI : 21.70 (-0.05%)
Albany Molecular Has Returned 41.1% Since SmarTrend Recommendation (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 3 months, Albany Molecular has returned 41.11% as of today's recent price of $21.71.

AMRI : 21.70 (-0.05%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Albany Molecular Research, Inc. - AMRI

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Albany Molecular Research,...

AMRI : 21.70 (-0.05%)
Albany Molecular Up 41.1% Since SmarTrend Uptrend Call (AMRI)

SmarTrend identified an Uptrend for Albany Molecular (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 2 months, Albany Molecular has returned 41.11% as of today's recent price of $21.71.

AMRI : 21.70 (-0.05%)
Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027

Research and Markets has announced the addition of the "Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027" report to their offering. Over the years, the biopharmaceutical market...

AMRI : 21.70 (-0.05%)
ADME-Toxicology Testing Market 2016-2024 - Global Strategic Business Report 2017

Research and Markets has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the...

A : 60.98 (-0.65%)
MKGAY : 39.0400 (+0.98%)
TCHBF : 191.0000 (unch)
COTXF : 1.5400 (unch)
PKI : 69.46 (+0.10%)
CMVLF : 27.0400 (-3.43%)
SLP : 15.15 (+4.84%)
AMRI : 21.70 (-0.05%)
GLPG : 80.85 (+6.16%)
LIFE : 3.40 (unch)
Pharmaceutical Contract Manufacturing & Contract Research Market to Reach $238 Billion by 2025 - Analysis By Services, CRO & Segment

Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing & Contract Research Market, 2014 - 2025" report to their offering. The global pharmaceutical contract manufacturing/contract...

VRX.TO : 22.13 (+1.89%)
WST : 93.48 (-0.60%)
ABBV : 74.01 (+1.70%)
CRL : 101.10 (+0.97%)
AMRI : 21.70 (-0.05%)
PFE : 33.54 (-0.24%)
EQUITY ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Albany Molecular Research, Inc. to The Carlyle Group and GTCR LLC is Fair to Shareholders - AMRI

NEW YORK, NY / ACCESSWIRE / June 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

AMRI : 21.70 (-0.05%)
Shares of AMRI Up 40.2% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on April 13th, 2017 at $15.39. In approximately 2 months, Albany Molecular Research has returned 40.20% as of today's recent...

AMRI : 21.70 (-0.05%)
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Albany Molecular Research, Inc. and Encourages Investors to Contact the Firm for Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

AMRI : 21.70 (-0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical...

See More

Support & Resistance

2nd Resistance Point 21.77
1st Resistance Point 21.73
Last Price 21.70
1st Support Level 21.68
2nd Support Level 21.67

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.